Synergistic effect of TRAIL and irradiation in elimination of glioblastoma stem-like cells

Clinical and Experimental Medicine
Junfeng LiuFei Ye

Abstract

Glioblastoma multiforme (GBM) is the most common malignancy in central nervous system. A small subpopulation of GBM cells known as GBM stem-like cells (GSLCs) were supposed to be the most malignant cells among GBM cells as they are resistant to multiple therapies including radiotherapy. In this study, we set up two GSLCs cell lines from the two parental U87 and U251 glioma cell lines, and studied the expression of apoptosis-related genes alteration in GSLCs before and after irradiation. We found that one of the receptors of TNF-related apoptosis-inducing ligand (TRAIL), DR5, was dramatically up-regulated in GSLCs after irradiation (IR). Although GSLCs are resistant to both TRAIL and radiation treatment alone, the combined treatment with TRAIL and irradiation achieved maximum killing effect of GSLCs due to inducing the expression of DR5 and inhibiting the expression of cFLIP. Therefore, TRAIL and IR combined treatment would be a simple but practical therapeutic strategy for clinical application.

References

Jul 10, 1997·Nature·M IrmlerJ Tschopp
Jul 20, 1999·The Journal of Clinical Investigation·A AshkenaziR H Schwall
Aug 6, 2000·Cell and Tissue Research·M Verheij, H Bartelink
Nov 2, 2001·Nature·T ReyaI L Weissman
Jun 18, 2002·Journal of Cellular and Molecular Medicine·N Shinomiya
Aug 2, 2008·The New England Journal of Medicine·Patrick Y Wen, Santosh Kesari
Jan 1, 2009·Nature Reviews. Drug Discovery·Véronique Baud, Michael Karin
Feb 25, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Cheng-Chia YuTai-Tong Wong
Sep 8, 2010·Expert Opinion on Therapeutic Targets·Junaid Abdulghani, Wafik S El-Deiry
Nov 11, 2011·Nature Reviews. Cancer·Xiangwei Wu, Scott M Lippman
Nov 16, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Yonghyun KimDo-Hyun Nam
Jul 4, 2012·Neurosurgery Clinics of North America·Winward ChoyIsaac Yang
Aug 18, 2012·The Journal of Pathology·Philipp Grosse-GehlingLeoni A Kunz-Schughart
Mar 9, 2013·Archives of Biochemistry and Biophysics·Srinivas RamasamySohail Ahmed
Mar 21, 2013·Stem Cell Research & Therapy·Barbara OrtensiGiuliana Pelicci
Apr 3, 2013·Current Protein & Peptide Science·Matteo SantoniStefano Cascinu
Jul 12, 2014·Cell Death and Differentiation·C R SchlegelA P Costa-Pereira
Aug 19, 2014·Trends in Pharmacological Sciences·Sahdeo PrasadBharat B Aggarwal
Apr 18, 2015·Journal of Hematology & Oncology·Axel SchulenburgPeter Valent
Apr 30, 2015·Trends in Cell Biology·Deborah A Flusberg, Peter K Sorger
May 4, 2015·Journal of Neuro-oncology·George A AlexiouAthanasios P Kyritsis
Apr 1, 2016·Cancer Biology & Therapy·Filiz SenbabaogluTugba Bagci-Onder

❮ Previous
Next ❯

Citations

Aug 11, 2021·Pharmaceutics·Adriana G Quiroz-ReyesElsa N Garza-Treviño

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.